Advertisement

Atrial Natriuretic Peptide (ANP) Protects Cells against Injury by Hypoxia and Hypochlorous Acid

  • A. A. von Ruecker
  • R. Pella
  • F. Bidlingmaier
Conference paper

Abstract

Recent reports show that ANP protects against post-ischemic renal failure in vivo and in the isolated perfused kidney [4, 8]. Since ANP has been shown to be a potent renal vasodilatator, this protective effect may be mediated exclusively by improving hemodynamics. To determine if ANP also has a protective effect at the cellular level, studies were performed in hepatocyte cell cultures. Hepatocytes showed a considerable increase in cellular cGMP content after ANP stimulation, suggesting the presence of ANP receptors. Cell cultures were exposed to hypoxia and reactive oxygen (hypochlorous acid, HClO), which cause cell damage similar to postischemic injury in vivo [3]. The following report demonstrates that ANP can protect cell cultures.

Key words

Atrial natriuretic peptide Cell protection Hypoxia Reactive oxygen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Costa AK, Heffel DF, Schieble TM, Trudell JR (1987) Toxicity of t-butylhydroperoxide in hepatocyte monolayers exposed to hypoxia and reoxygenation. In Vitro Cell Develop Biol 23: 501–506CrossRefGoogle Scholar
  2. 2.
    Leitman DC, Agnost VL, Tuan JJ, Andresen JW, Murad F (1987) Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase. Biochem J 244: 69–74PubMedGoogle Scholar
  3. 3.
    McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159–163PubMedCrossRefGoogle Scholar
  4. 4.
    Nakamoto M, Shapiro JI, Shanley PF, Chan L, Shrier RW (1987) In vitro and in vivo protective effect of atriopeptin IH on ischemic acute renal failure, J Clin Invest 80: 698–705PubMedCrossRefGoogle Scholar
  5. 5.
    O’Donnell ME, Owen NE (1986) Role of cyclic GMP in atrial natriuretic factor stimulation of Na+, K+, Cl-cotransport in vascular smooth muscle cells. J Biol Chem 261: 15461–15466PubMedGoogle Scholar
  6. 6.
    Rao GS, Lemoch H, Kessler H, Damm I, Eiermann V, Koll S, Zarbock J, Usadel KH (1986) Prevention of phalloidin-induced lesions in isolated rat hepatocytes by novel synthetic analogues of somatostatin. Klin Wochenschr 64 [Suppl VII]: 79–86PubMedGoogle Scholar
  7. 7.
    von Ruecker AA, Rao G, Bidlingmaier F (1988) Cyclosporin A inhibits proteolytic cleavage and degradation of membrane bound protein kinase C in hepatocytes after stimulation by phorbol ester. Biochem Biophys Res Commun 151: 997–1003CrossRefGoogle Scholar
  8. 8.
    Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A (1987) Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 80: 1232–1237PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • A. A. von Ruecker
    • 1
  • R. Pella
    • 1
  • F. Bidlingmaier
    • 1
  1. 1.Institut für Klinische BiochemieUniversität BonnGermany

Personalised recommendations